The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) ‐ EMA Joint Big Data Task Force

The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) ‐ EMA Joint Big Data Task Force

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacoepidemiology and drug safety 2019-12, Vol.28 (12), p.1640-1641
Hauptverfasser: Pottegård, Anton, Klungel, Olaf, Winterstein, Almut, Huybrechts, Krista, Hallas, Jesper, Schneeweiss, Sebastian, Evans, Stephen, Bate, Andrew, Pont, Lisa, Trifirò, Gianluca, Smith, Meredith, Bourke, Alison
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1641
container_issue 12
container_start_page 1640
container_title Pharmacoepidemiology and drug safety
container_volume 28
creator Pottegård, Anton
Klungel, Olaf
Winterstein, Almut
Huybrechts, Krista
Hallas, Jesper
Schneeweiss, Sebastian
Evans, Stephen
Bate, Andrew
Pont, Lisa
Trifirò, Gianluca
Smith, Meredith
Bourke, Alison
description
doi_str_mv 10.1002/pds.4911
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2308121940</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2308121940</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3831-4b68e035f17b9516e00f7974faba30f006e1683d09b20b9521cce5533a3f27af3</originalsourceid><addsrcrecordid>eNp1kcFu1DAQhiMEoqUg8QRoJA6UQ4od20l8XLYtW9QVFbucI8cZb10Se7ETob3xCLwLb8STkOwWkJA4zYzn02dp_iR5TskZJSR7s23iGZeUPkiOKZEypUIUD6desLQUuTxKnsR4R8i4k_xxcsRozjMq-HHyY32LcOV6DE711jvVwspri_0OjA9wc6tCp7THrW2ws771m92rCHPfdej6CN5BPwrmPiB8RL1_bvaiCPawWw1dp8IOvNmPC1RNnIYlNlZbhxFmG3TjlxFOF8vZa_j57TtcLGfw3lvXw1u7gXPVK1ir-BkufdD4NHlkVBvx2X09ST5dXqzni_T6w7ur-ew61axkNOV1XiJhwtCiloLmSIgpZMGNqhUjhpAcaV6yhsg6IyORUa1RCMYUM1mhDDtJTg_ebfBfBox91dmosW2VQz_EKmOkpBmVnIzoy3_QOz-MJ20nKuN5JjkTf4U6-BgDmmob7HScipJqCrIag6ymIEf0xb1wqDts_oC_kxuB9AB8tS3u_iuqbs5Xe-EvoKinDg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2324629435</pqid></control><display><type>article</type><title>The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) ‐ EMA Joint Big Data Task Force</title><source>Wiley-Blackwell Journals</source><creator>Pottegård, Anton ; Klungel, Olaf ; Winterstein, Almut ; Huybrechts, Krista ; Hallas, Jesper ; Schneeweiss, Sebastian ; Evans, Stephen ; Bate, Andrew ; Pont, Lisa ; Trifirò, Gianluca ; Smith, Meredith ; Bourke, Alison</creator><creatorcontrib>Pottegård, Anton ; Klungel, Olaf ; Winterstein, Almut ; Huybrechts, Krista ; Hallas, Jesper ; Schneeweiss, Sebastian ; Evans, Stephen ; Bate, Andrew ; Pont, Lisa ; Trifirò, Gianluca ; Smith, Meredith ; Bourke, Alison</creatorcontrib><identifier>ISSN: 1053-8569</identifier><identifier>EISSN: 1099-1557</identifier><identifier>DOI: 10.1002/pds.4911</identifier><identifier>PMID: 31642154</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><ispartof>Pharmacoepidemiology and drug safety, 2019-12, Vol.28 (12), p.1640-1641</ispartof><rights>2019 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3831-4b68e035f17b9516e00f7974faba30f006e1683d09b20b9521cce5533a3f27af3</citedby><cites>FETCH-LOGICAL-c3831-4b68e035f17b9516e00f7974faba30f006e1683d09b20b9521cce5533a3f27af3</cites><orcidid>0000-0002-8097-8708 ; 0000-0003-3151-3653 ; 0000-0001-9314-5679 ; 0000-0001-5805-8430 ; 0000-0002-0005-9016</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpds.4911$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpds.4911$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31642154$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pottegård, Anton</creatorcontrib><creatorcontrib>Klungel, Olaf</creatorcontrib><creatorcontrib>Winterstein, Almut</creatorcontrib><creatorcontrib>Huybrechts, Krista</creatorcontrib><creatorcontrib>Hallas, Jesper</creatorcontrib><creatorcontrib>Schneeweiss, Sebastian</creatorcontrib><creatorcontrib>Evans, Stephen</creatorcontrib><creatorcontrib>Bate, Andrew</creatorcontrib><creatorcontrib>Pont, Lisa</creatorcontrib><creatorcontrib>Trifirò, Gianluca</creatorcontrib><creatorcontrib>Smith, Meredith</creatorcontrib><creatorcontrib>Bourke, Alison</creatorcontrib><title>The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) ‐ EMA Joint Big Data Task Force</title><title>Pharmacoepidemiology and drug safety</title><addtitle>Pharmacoepidemiol Drug Saf</addtitle><issn>1053-8569</issn><issn>1099-1557</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kcFu1DAQhiMEoqUg8QRoJA6UQ4od20l8XLYtW9QVFbucI8cZb10Se7ETob3xCLwLb8STkOwWkJA4zYzn02dp_iR5TskZJSR7s23iGZeUPkiOKZEypUIUD6desLQUuTxKnsR4R8i4k_xxcsRozjMq-HHyY32LcOV6DE711jvVwspri_0OjA9wc6tCp7THrW2ws771m92rCHPfdej6CN5BPwrmPiB8RL1_bvaiCPawWw1dp8IOvNmPC1RNnIYlNlZbhxFmG3TjlxFOF8vZa_j57TtcLGfw3lvXw1u7gXPVK1ir-BkufdD4NHlkVBvx2X09ST5dXqzni_T6w7ur-ew61axkNOV1XiJhwtCiloLmSIgpZMGNqhUjhpAcaV6yhsg6IyORUa1RCMYUM1mhDDtJTg_ebfBfBox91dmosW2VQz_EKmOkpBmVnIzoy3_QOz-MJ20nKuN5JjkTf4U6-BgDmmob7HScipJqCrIag6ymIEf0xb1wqDts_oC_kxuB9AB8tS3u_iuqbs5Xe-EvoKinDg</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Pottegård, Anton</creator><creator>Klungel, Olaf</creator><creator>Winterstein, Almut</creator><creator>Huybrechts, Krista</creator><creator>Hallas, Jesper</creator><creator>Schneeweiss, Sebastian</creator><creator>Evans, Stephen</creator><creator>Bate, Andrew</creator><creator>Pont, Lisa</creator><creator>Trifirò, Gianluca</creator><creator>Smith, Meredith</creator><creator>Bourke, Alison</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8097-8708</orcidid><orcidid>https://orcid.org/0000-0003-3151-3653</orcidid><orcidid>https://orcid.org/0000-0001-9314-5679</orcidid><orcidid>https://orcid.org/0000-0001-5805-8430</orcidid><orcidid>https://orcid.org/0000-0002-0005-9016</orcidid></search><sort><creationdate>201912</creationdate><title>The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) ‐ EMA Joint Big Data Task Force</title><author>Pottegård, Anton ; Klungel, Olaf ; Winterstein, Almut ; Huybrechts, Krista ; Hallas, Jesper ; Schneeweiss, Sebastian ; Evans, Stephen ; Bate, Andrew ; Pont, Lisa ; Trifirò, Gianluca ; Smith, Meredith ; Bourke, Alison</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3831-4b68e035f17b9516e00f7974faba30f006e1683d09b20b9521cce5533a3f27af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pottegård, Anton</creatorcontrib><creatorcontrib>Klungel, Olaf</creatorcontrib><creatorcontrib>Winterstein, Almut</creatorcontrib><creatorcontrib>Huybrechts, Krista</creatorcontrib><creatorcontrib>Hallas, Jesper</creatorcontrib><creatorcontrib>Schneeweiss, Sebastian</creatorcontrib><creatorcontrib>Evans, Stephen</creatorcontrib><creatorcontrib>Bate, Andrew</creatorcontrib><creatorcontrib>Pont, Lisa</creatorcontrib><creatorcontrib>Trifirò, Gianluca</creatorcontrib><creatorcontrib>Smith, Meredith</creatorcontrib><creatorcontrib>Bourke, Alison</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacoepidemiology and drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pottegård, Anton</au><au>Klungel, Olaf</au><au>Winterstein, Almut</au><au>Huybrechts, Krista</au><au>Hallas, Jesper</au><au>Schneeweiss, Sebastian</au><au>Evans, Stephen</au><au>Bate, Andrew</au><au>Pont, Lisa</au><au>Trifirò, Gianluca</au><au>Smith, Meredith</au><au>Bourke, Alison</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) ‐ EMA Joint Big Data Task Force</atitle><jtitle>Pharmacoepidemiology and drug safety</jtitle><addtitle>Pharmacoepidemiol Drug Saf</addtitle><date>2019-12</date><risdate>2019</risdate><volume>28</volume><issue>12</issue><spage>1640</spage><epage>1641</epage><pages>1640-1641</pages><issn>1053-8569</issn><eissn>1099-1557</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31642154</pmid><doi>10.1002/pds.4911</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-8097-8708</orcidid><orcidid>https://orcid.org/0000-0003-3151-3653</orcidid><orcidid>https://orcid.org/0000-0001-9314-5679</orcidid><orcidid>https://orcid.org/0000-0001-5805-8430</orcidid><orcidid>https://orcid.org/0000-0002-0005-9016</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1053-8569
ispartof Pharmacoepidemiology and drug safety, 2019-12, Vol.28 (12), p.1640-1641
issn 1053-8569
1099-1557
language eng
recordid cdi_proquest_miscellaneous_2308121940
source Wiley-Blackwell Journals
title The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) ‐ EMA Joint Big Data Task Force
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T18%3A23%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20International%20Society%20for%20Pharmacoepidemiology's%20Comments%20on%20the%20Core%20Recommendations%20in%20the%20Summary%20of%20the%20Heads%20of%20Medicines%20Agencies%20(HMA)%20%E2%80%90%20EMA%20Joint%20Big%20Data%20Task%20Force&rft.jtitle=Pharmacoepidemiology%20and%20drug%20safety&rft.au=Potteg%C3%A5rd,%20Anton&rft.date=2019-12&rft.volume=28&rft.issue=12&rft.spage=1640&rft.epage=1641&rft.pages=1640-1641&rft.issn=1053-8569&rft.eissn=1099-1557&rft_id=info:doi/10.1002/pds.4911&rft_dat=%3Cproquest_cross%3E2308121940%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2324629435&rft_id=info:pmid/31642154&rfr_iscdi=true